tiprankstipranks
Advertisement
Advertisement

MDCX Stock Latest News

Medicus Pharma enters media partnership with New to The Street
The FlyMedicus Pharma enters media partnership with New to The Street
6d ago
MDCX
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
PremiumCompany Announcements
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
7d ago
MDCX
Medicus Pharma submits clinical study design to FDA for Teverelix
PremiumThe Fly
Medicus Pharma submits clinical study design to FDA for Teverelix
7d ago
MDCX
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
PremiumCompany Announcements
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
12d ago
MDCX
Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate
PremiumCompany Announcements
Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate
14d ago
MDCX
Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2
PremiumCompany AnnouncementsMedicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2
14d ago
MDCX
Medicus Pharma reports principal investigator validation of Phase 2 data
Premium
The Fly
Medicus Pharma reports principal investigator validation of Phase 2 data
14d ago
MDCX
Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan
Premium
Company Announcements
Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan
18d ago
MDCX
Medicus Pharma Advances SkinJect and Teverelix Pipelines, Adds AI to Clinical Strategy
PremiumCompany Announcements
Medicus Pharma Advances SkinJect and Teverelix Pipelines, Adds AI to Clinical Strategy
19d ago
MDCX
Medicus Pharma Showcases Strong Phase 2 SkinJect Data Ahead of Fireside Chat
PremiumCompany Announcements
Medicus Pharma Showcases Strong Phase 2 SkinJect Data Ahead of Fireside Chat
26d ago
MDCX
Medicus Pharma to discuss Skinject Phase 2 reults in fireside chat
PremiumThe Fly
Medicus Pharma to discuss Skinject Phase 2 reults in fireside chat
26d ago
MDCX
Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call
PremiumCompany Announcements
Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call
28d ago
MDCX
Medicus Pharma announces SkinJect Phase 2 KOL update
PremiumThe FlyMedicus Pharma announces SkinJect Phase 2 KOL update
28d ago
MDCX
Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum
Premium
Company Announcements
Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum
1M ago
MDCX
Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma
Premium
Company Announcements
Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma
1M ago
MDCX
Medicus Pharma provides interpretation of Phase 2 SkinJect dataset
PremiumThe Fly
Medicus Pharma provides interpretation of Phase 2 SkinJect dataset
1M ago
MDCX
Medicus Pharma Raises Equity Financing, Reduces Yorkville Debenture
PremiumCompany Announcements
Medicus Pharma Raises Equity Financing, Reduces Yorkville Debenture
1M ago
8K
MDCX
Medicus Pharma Posts Strong Phase 2 Data for Microneedle Basal Cell Carcinoma Therapy
PremiumCompany Announcements
Medicus Pharma Posts Strong Phase 2 Data for Microneedle Basal Cell Carcinoma Therapy
1M ago
MDCX
Medicus Pharma announces results from Phase 2 study of D-MNA
PremiumThe Fly
Medicus Pharma announces results from Phase 2 study of D-MNA
1M ago
MDCX
Medicus Pharma announces results from Phase 2 study of D-MNA
PremiumThe FlyMedicus Pharma announces results from Phase 2 study of D-MNA
1M ago
MDCX
Medicus Pharma Showcases SkinJect and Teverelix Strategy at Roth Conference
Premium
Company Announcements
Medicus Pharma Showcases SkinJect and Teverelix Strategy at Roth Conference
1M ago
MDCX
Medicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer
Premium
Company Announcements
Medicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer
2M ago
MDCX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >